Brandon Folkes
Stock Analyst at H.C. Wainwright
(2.41)
# 3,065
Out of 4,988 analysts
526
Total ratings
41.9%
Success rate
0.7%
Average return
Main Sectors:
Stocks Rated by Brandon Folkes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNTB Connect Biopharma Holdings | Reiterated: Buy | $7 | $1.28 | +446.88% | 18 | Sep 17, 2026 | |
| XERS Xeris Biopharma Holdings | Reiterated: Buy | $10 | $8.20 | +21.95% | 8 | Sep 10, 2026 | |
| MIST Milestone Pharmaceuticals | Reiterated: Buy | $8 | $0.9158 | +773.55% | 16 | Sep 4, 2026 | |
| SGMT Sagimet Biosciences | Reiterated: Buy | $29 | $11.09 | +161.50% | 10 | Aug 26, 2026 | |
| RANI Rani Therapeutics Holdings | Reiterated: Buy | $11 | $0.862 | +1,176.10% | 11 | Aug 21, 2026 | |
| ZVRA Zevra Therapeutics | Reiterated: Buy | $26 | $11.61 | +123.94% | 15 | Aug 21, 2026 | |
| RNTX Rein Therapeutics | Reiterated: Buy | $8 | $0.80 | +900.00% | 9 | Aug 18, 2026 | |
| TRAW Traws Pharma | Reiterated: Hold | $1 | $0.49 | +104.08% | 5 | Aug 18, 2026 | |
| HRTX Heron Therapeutics | Downgraded: Hold | n/a | $0.3097 | - | 40 | Aug 17, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $13 | $7.72 | +68.39% | 13 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $22.65 | +164.90% | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12.59 | $2.61 | +382.27% | 14 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 | $6.55 | +174.81% | 9 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $7.31 | +77.84% | 9 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $17.87 | +84.67% | 26 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.21 | +149.52% | 11 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.73 | +478.03% | 3 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.16 | +158.62% | 20 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15.40 | $11.97 | +28.63% | 17 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $7.98 | +50.38% | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $121 | $76.14 | +58.92% | 23 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $12.20 | +63.93% | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $14.95 | +60.54% | 14 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $22.77 | +163.50% | 41 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $3.54 | +182.49% | 25 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $34.88 | +37.61% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 → $200 | $4.86 | n/a | 2 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $8.07 | n/a | 5 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 → $16 | $6.80 | n/a | 29 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 → $4 | $2.65 | n/a | 5 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $10 | $0.85 | n/a | 2 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.000001 | n/a | 3 | Mar 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $37 → $33 | $1.29 | n/a | 18 | Mar 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $15 | $2.41 | n/a | 15 | Feb 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $48 | $238.54 | n/a | 1 | Feb 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $40 | $0.5683 | n/a | 2 | Nov 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5 | $0.0003 | n/a | 1 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $50 | $0.0112 | n/a | 3 | Mar 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $22 → $32 | $43.39 | n/a | 12 | Jan 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $25 | $44.23 | n/a | 3 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $240.74 | n/a | 10 | Oct 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $8 | $0.000001 | n/a | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $35.07 | n/a | 1 | Jun 30, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $12 | $9.60 | n/a | 9 | May 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $33 | $18.09 | n/a | 2 | Dec 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $34 → $30 | $34.56 | n/a | 2 | Sep 12, 2016 |
Connect Biopharma Holdings
Sep 17, 2026
Reiterated: Buy
Price Target: $7
Current: $1.28
Upside: +446.88%
Xeris Biopharma Holdings
Sep 10, 2026
Reiterated: Buy
Price Target: $10
Current: $8.20
Upside: +21.95%
Milestone Pharmaceuticals
Sep 4, 2026
Reiterated: Buy
Price Target: $8
Current: $0.9158
Upside: +773.55%
Sagimet Biosciences
Aug 26, 2026
Reiterated: Buy
Price Target: $29
Current: $11.09
Upside: +161.50%
Rani Therapeutics Holdings
Aug 21, 2026
Reiterated: Buy
Price Target: $11
Current: $0.862
Upside: +1,176.10%
Zevra Therapeutics
Aug 21, 2026
Reiterated: Buy
Price Target: $26
Current: $11.61
Upside: +123.94%
Rein Therapeutics
Aug 18, 2026
Reiterated: Buy
Price Target: $8
Current: $0.80
Upside: +900.00%
Traws Pharma
Aug 18, 2026
Reiterated: Hold
Price Target: $1
Current: $0.49
Upside: +104.08%
Heron Therapeutics
Aug 17, 2026
Downgraded: Hold
Price Target: n/a
Current: $0.3097
Upside: -
CorMedix
Aug 14, 2026
Reiterated: Buy
Price Target: $13
Current: $7.72
Upside: +68.39%
Aug 14, 2026
Reiterated: Buy
Price Target: $60
Current: $22.65
Upside: +164.90%
Aug 14, 2026
Reiterated: Buy
Price Target: $12.59
Current: $2.61
Upside: +382.27%
Aug 14, 2026
Reiterated: Buy
Price Target: $18
Current: $6.55
Upside: +174.81%
Aug 13, 2026
Reiterated: Buy
Price Target: $13
Current: $7.31
Upside: +77.84%
Aug 13, 2026
Reiterated: Buy
Price Target: $33
Current: $17.87
Upside: +84.67%
Aug 13, 2026
Reiterated: Buy
Price Target: $13
Current: $5.21
Upside: +149.52%
Aug 13, 2026
Reiterated: Buy
Price Target: $10
Current: $1.73
Upside: +478.03%
Aug 13, 2026
Reiterated: Buy
Price Target: $3
Current: $1.16
Upside: +158.62%
Aug 13, 2026
Reiterated: Buy
Price Target: $15.40
Current: $11.97
Upside: +28.63%
Aug 11, 2026
Reiterated: Buy
Price Target: $12
Current: $7.98
Upside: +50.38%
Aug 11, 2026
Reiterated: Buy
Price Target: $121
Current: $76.14
Upside: +58.92%
Aug 11, 2026
Reiterated: Buy
Price Target: $20
Current: $12.20
Upside: +63.93%
Aug 11, 2026
Reiterated: Buy
Price Target: $24
Current: $14.95
Upside: +60.54%
Aug 7, 2026
Reiterated: Buy
Price Target: $60
Current: $22.77
Upside: +163.50%
Aug 6, 2026
Reiterated: Buy
Price Target: $10
Current: $3.54
Upside: +182.49%
Aug 4, 2026
Reiterated: Buy
Price Target: $48
Current: $34.88
Upside: +37.61%
Mar 4, 2025
Reiterated: Buy
Price Target: $8 → $200
Current: $4.86
Upside: n/a
Nov 14, 2024
Initiated Coverage: Buy
Price Target: $5
Current: $8.07
Upside: n/a
Aug 22, 2024
Initiated Coverage: Buy
Price Target: $23 → $16
Current: $6.80
Upside: n/a
May 3, 2024
Reiterated: Buy
Price Target: $3 → $4
Current: $2.65
Upside: n/a
May 12, 2023
Reiterated: Buy
Price Target: $20 → $10
Current: $0.85
Upside: n/a
Mar 17, 2023
Rated: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Mar 13, 2023
Reiterated: Hold
Price Target: $37 → $33
Current: $1.29
Upside: n/a
Feb 9, 2023
Reiterated: Buy
Price Target: $22 → $15
Current: $2.41
Upside: n/a
Feb 3, 2023
Reiterated: Buy
Price Target: $48
Current: $238.54
Upside: n/a
Nov 22, 2022
Reiterated: Buy
Price Target: $22 → $40
Current: $0.5683
Upside: n/a
Nov 2, 2022
Initiated Coverage: Buy
Price Target: $5
Current: $0.0003
Upside: n/a
Mar 31, 2022
Reiterated: Buy
Price Target: $5 → $50
Current: $0.0112
Upside: n/a
Jan 27, 2022
Upgraded: Buy
Price Target: $22 → $32
Current: $43.39
Upside: n/a
Nov 4, 2021
Reiterated: Buy
Price Target: $23 → $25
Current: $44.23
Upside: n/a
Oct 6, 2021
Reiterated: Buy
Price Target: $210
Current: $240.74
Upside: n/a
Aug 9, 2021
Reiterated: Buy
Price Target: $6 → $8
Current: $0.000001
Upside: n/a
Jun 30, 2021
Initiated Coverage: Buy
Price Target: $45
Current: $35.07
Upside: n/a
May 6, 2021
Reiterated: Buy
Price Target: $18 → $12
Current: $9.60
Upside: n/a
Dec 15, 2020
Reiterated: Buy
Price Target: $25 → $33
Current: $18.09
Upside: n/a
Sep 12, 2016
Reiterated: Buy
Price Target: $34 → $30
Current: $34.56
Upside: n/a